Chicago, IL · Founded 2013 · Privately Held (backing)
Developer of a precision health technology designed for doctors to identify and manage patients at high risk for cancer. CancerIQ is based in Chicago, IL and was founded in 2013. Its last reported valuation was $50 million in Mar 2022. It has raised $30.8 million.
Last reported valuation
$50.0M
Oct 2026
Priced at
—
Total raised
$30.8M
Last round
—
Cap table — not yet on record
CancerIQ's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of CancerIQ with a free account
·The complete investor list: 26 names
·Watch CancerIQ: the Monday email on marks, rounds and moves
